As France goes to elect a new president, the leading engineering schools constituting ParisTech have obtained their first official recognition by the French government.
In a rare example of a university tec transfer deal attracting an upfront payment, French pharma company Ipsen paying €1.25 million for a treatment licence.
Just few days after the announcement of cut in its biology budget, France’s leading public research organisation is going flat out for industrial contracts.
Innate Pharma SA has applied for an initial public offering and listing on the Euronext in Paris, to raise funds to expand its pipeline of oncology therapeutics.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.